BioPorto, a vitro diagnostics company, announced the appointment of Dr. Prasad Devarajan as Senior Medical Director effective July 1, 2022. Dr. Devarajan is considered a world leading Pediatric Nephrologist and physician-scientist and a pioneer in understanding the relationship between Neutrophil gelatinase-associated lipocalin (NGAL) and Acute Kidney Injury (AKI), a statement said. Dr. Devarajan is Professor…